SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VICL (Vical Labs)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1972 55 0 VICL
Emcee:  bob clark Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1422Vical Announces Management Changes SAN DIEGO, June 6 /PRNewswire/ -- Vical Incobob zagorin-6/7/2001
1421Gene Therapy Cuts Cholesterol In Mice Gene therapy can successfully lower cholbob zagorin-6/1/2001
1420Vical Presents Clinical Safety and Efficacy Data Summary And Preclinical Progresbob zagorin-5/31/2001
1419Vical Announces Management Changes SAN DIEGO, May 30 /PRNewswire/ -- Vical Incobob zagorin-5/31/2001
1418Bob, Nice article - Thanks! Scott (eom)Scott H. Davis-5/23/2001
1417American Society for Microbiology General Meeting, Florida lifelines: Virus crosbob zagorin-5/23/2001
1416It is Vical. See Yahoo board on Vical, message 4962.Tagore-5/22/2001
1415sounds like VICL to me. comments? Gene Therapy Potent Against Advanced Prostatebob zagorin-5/21/2001
1414Way Way too early to get excited.....need a double blind control study.puborectalis-5/16/2001
1413Doctors report nerve repair in gene therapy By Globe Staff, 5/15/2001 octors bob zagorin-5/16/2001
1412Market response makes very little sense so far. Good news, and VICl is slippingScott H. Davis-5/16/2001
1411Source: Thomas Jefferson University Hospital Date Posted: Tuesdabob zagorin-5/15/2001
1410Preliminary Research Displays Progress for Cancer Vaccines By DAVID P. HAMILTON bob zagorin-5/14/2001
1409Vical Presents Promising Interim Data From Phase II Allovectin-7(R) Melanoma RegScott H. Davis-5/14/2001
1408All: Some vaccine observations from a father who's son's life was profoScott H. Davis-5/13/2001
1407Bob, This is why the HGSI related company licensed VCIAL technology - VICl was gScott H. Davis-5/13/2001
1406Catching up after being out all week. The impression I'm getting (releases,Scott H. Davis-5/13/2001
1405Navy Wages Biotech War On Malaria signalsmag.comsmh-5/12/2001
1404here's another VEGF story. although VICL's patent would deliver it, i stbob zagorin-5/9/2001
1403I'm fairly intrigued with this angiogenesis patent. i've always thought bob zagorin-5/8/2001
1402Vical Announces Issuance of Angiogenesis Patent SAN DIEGO, May 8 /PRNewswire/ -bob zagorin-5/8/2001
1401Vical Announces First-Quarter 2001 Financial Results; Increased Revenues Reduce bob zagorin-5/7/2001
1400Scott, Maybe they will announce the successful end of the Allovectin-7 RegistraWilliam Strop-5/5/2001
1399Interesting timing on these events:May12-15 American Society of Clinical OncologScott H. Davis-5/2/2001
1398Vical CEO to Speak at Biotech Stocks Investment Forum SAN DIEGO, May 2 /PRNewswbob zagorin-5/2/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News